dG (iPr-Pac) Me-Phosphoramidite
dG (iPr-Pac) Me-Phosphoramidite
dG (iPr-Pac) Me-Phosphoramidite, 250 mg, ABI (8 mL / 20 mm Septum)
Key features
Show- Useful for creating nuclease resistant methyl phosphotriester linkage.
- Applications in nucleic acid therapeutics.
- Compatible with UltraMILD synthesis.
Usually shipped in 3-5 days, Packed To Order
Product information
The UltraMILD set of methyl phosphoramidites, in conjunction with UltraMILD deprotection conditions, can be used to prepare the interesting, nuclease resistant methyl phosphotriester linkage. These have potential therapeutic applications.
We also produce a range of ethyl phosphoramidites with classical nucleobase protection. Nuclease resistant P-ethoxy oligonucleotides (a hydrophobic analogue of phosphodiesters) have been shown, through incorporation into liposomes, to be effective in the inhibition of protein expression and cell growth in therapeutic applications.(1) The neutral charge and slight lipophilic character appears to improve the delivery of the oligonucleotide into a cell.
Ref:
- (a) Cellular pharmacology of P-ethoxy antisense oligonucleotides targeted to Bcl-2 in a follicular lymphoma cell line, Y. Gutiérrez-Puente, A.M. Tari, R.J. Ford, R. Tamez-Guerra, R. Mercado-Hernandez, M. Santoyo-Stephano, and G. Lopez-Berestein, Leuk. Lymphoma., 44, 1979-85, 2003. (b) Safety, pharmacokinetics, and tissue distribution of liposomal P-ethoxy antisense oligonucleotides targeted to Bcl-2, Y. Gutiérrez-Puente, A.M. Tari, C. Stephens, M. Rosenblum, R.T. Guerra, G. Lopez-Berestein, J. Pharmacol. Exp. Ther., 291, 865-9, 1999.
Applicable Products
LK2050 | Ac-dC-Me Phosphoramidite |
LK2051 | iPr-Pac-dG-Me Phosphoramidite |
LK2052 | Pac-dA-Me Phosphoramidite |
LK2078 | dT-Me Phosphoramidite |
Physical & Dilution Data
Unit weights are expressed for the methyl triester form. Dilution volumes (in ml) are for 0.1M solutions in dry acetonitrile (LK4050) Adjust accordingly for other concentrations. For µmol pack sizes, products should be diluted as 100µmol/ml to achieve 0.1M, regardless of molecular weight.
Item |
Mol. Formula |
Mol. Wt. |
Unit Wt. |
250mg |
500mg |
1g |
LK2050 | C39H49N4O8P | 732.81 | 303.21 | 3.41 | 6.82 | 13.65 |
LK2051 | C49H59N6O9P | 907.21 | 343.23 | 2.76 | 5.51 | 11.03 |
LK2052 | C46H53N6O8P | 848.93 | 327.23 | 2.94 | 5.89 | 11.78 |
LK2078 | C38H48N3O8P | 705.79 | 318.22 | 3.54 | 7.08 | 14.17 |
Coupling
No changes are required from the standard method recommended by the synthesiser manufacturer. Coupling is as per standard nucleoside amidites. If the oligo contains many dG residues, use phenoxyacetic anhydride in the Cap Mix A (LK4210) to avoid the exchange of the iPr-Pac group on the dG with acetate from the acetic anhydride capping mix.
Deprotection
Use UltraMILD deprotection with 0.05M potassium carbonate in methanol to leave the methyl triester intact.1
Storage & Stability
Refrigerate the solids at a maximum of 2-8°C. Stability in solution is 2-3 days.
Reference
- See also: T. Atkinson and M. Smith in Oligonucleotide synthesis: a Practical Approach, M.J. Gait (editor), IRL Press Limited, Oxford, 1984, pages 68-70.
Access support
Need some support with placing an order, setting up an account, or finding the right protocol?
Contact us